Powered by S4AI · BrainMAAS v2.136 board-certified AI specialist agents deliberate in real time across oncology, neurology, and cross-disciplinary boards. Evidence-based, patient-centered, with full governance and audit trails.
A complete simulation of multi-disciplinary clinical deliberation — from intake to treatment plan.
36 specialist agents with distinct personas, knowledge domains, and board certifications assess each case independently, then engage in live group discussion.
Automatic agent activation based on ICD-10 diagnosis codes and CPT procedure codes. Visual routing hierarchy shows exactly which codes triggered which specialists.
Patient values, goals, and preferences anchor every recommendation. Trade-off decisions are framed in the patient's own language with explicit alternatives.
Tiered decision framework with formal rulings, stopping rules, and evidence-based escalation triggers. No silent reversals — every change requires justification.
Automated validator scans the full deliberation record for contradictions, reversed decisions, and guideline inconsistencies. Issues PASS/WARN/FAIL verdicts.
8-phase evidence pipeline: load context, identify sources, analyze artifacts, search databases, generate questions, cross-reference, deep dive, synthesize report.
Clinical Librarian, Medical Ordering Clinician, and Pharmacy Informatics review every round — evidence audit, order sets, drug interaction screening.
Two professional documents: Deliberation Record (process transparency) and Clinical Report (organized by specialist domain). Both with governance rulings and citations.
Animated visualization with particle effects, agent processing states, cognitive process triggers, sub-agent invocations, and council deliberation — all synced with Gemini.
From patient intake to treatment plan in three structured rounds.
Enter patient details, upload EHR documents, imaging, and lab results. Run deep research to compile evidence.
Specialist agents produce independent assessments. Each sees patient values, governance rulings, and research evidence.
Agents converse in a live tumor board discussion. They challenge, agree, and build on each other's recommendations.
Chairman synthesizes consensus, validates consistency, frames risk-benefit for the patient, and generates downloadable reports.
Based on the BrainMAAS v2.1 architecture — a 5-layer cognitive engine with neurochemical analogs.
Each agent has a distinct persona, knowledge domains, ICD-10 focus, and escalation triggers.
Sign in with your Microsoft 365 account to access the full simulation platform.